Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
3.04Enterprise Value over EBIT
VS
Market
Sector
Industry
History
$ 5.47Close
$ 2.42 - $ 5.73 52-Week Range
Ticker Information
Ticker
PBYICompany Name
PUMA BIOTECHNOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQPUMA BIOTECHNOLOGY INC - Enterprise Value over EBIT Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
PBYI - EV/EBIT Historical data
| Date | Earning Before Interest & Taxes (EBIT) | Enterprise Value | Enterprise Value over EBIT |
|---|---|---|---|
| 6/30/2025 | $ 52.01M | $ 158.2M | 3.04 |
| 3/31/2025 | $ 43.23M | $ 151.07M | 3.49 |
| 12/31/2024 | $ 36.55M | $ 153.2M | 4.19 |
| 9/30/2024 | $ 37.85M | $ 167.84M | 4.43 |
| 6/30/2024 | $ 23.49M | $ 203.1M | 8.65 |
| 3/31/2024 | $ 29.91M | $ 273.25M | 9.14 |
| 12/31/2023 | $ 36M | $ 326.75M | 9.08 |
| 9/30/2023 | $ 17.81M | $ 148.87M | 8.36 |
| 6/30/2023 | $ 11.12M | $ 220.16M | 19.8 |
| 3/31/2023 | $ 17.61M | $ 174.15M | 9.89 |
Key Performance Insights, Last 5 Years
- PUMA BIOTECHNOLOGY INC's latest trailing twelve months (TTM) EV/EBIT stands at 0.
- Over the past 5 years, PUMA BIOTECHNOLOGY INC's average EV/EBIT has been 8.75.
- The median EV/EBIT for PUMA BIOTECHNOLOGY INC during this period was 8.5
- PUMA BIOTECHNOLOGY INC reached its highest EV/EBIT over the past 5 years at 19.8.
- The lowest EV/EBIT recorded by PUMA BIOTECHNOLOGY INC in the same timeframe 3.04
PUMA BIOTECHNOLOGY INC's EV/EBIT vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EV/EBIT Benchmarks
Similar metrics to EV/EBIT:
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Earning Before Interest & Taxes (EBIT) - [Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].
- Enterprise Value - [Calculation] Enterprise value (EV) refers to the total value of a business and is frequently used as a more elaborate substitute for market capitalization. EV is calculated as a company's [MarketCap] plus its [Debt] minus cash and cash equivalents [CashnEq].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
Definition of Enterprise Value over EBIT
[Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest and taxes [EBIT].EV / EBIT
(=) EV/EBIT EV/EBIT for PUMA BIOTECHNOLOGY INC is calculated as follows: EV [ $ 358.62M ] / EBIT [ $ -42.65M ]
(=) EV/EBIT [ 0 ] PBYI - Enterprise Value over EBIT, Last 5 years
3.04
Minimum
Jun 30, 2025
19.8
Maximum
Jun 30, 2023
8.75
Average
8.5
Median
EV/EBIT Benchmark AnalysisMarket
The chart above depicts the distribution of EV/EBIT for companies in the Total Stock Market. The average EV/EBIT of the companies is 19.91 with a standard deviation of 12.32.
The following table provides additional summary stats:
EV/EBIT in the Market:
| filtered constituents | 2.25K |
|---|---|
| min | 0.05 |
| max | 62.03 |
| average | 19.91 |
| median | 16.78 |
| std | 12.32 |